Metagenomi, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +6,978.2% | +160.2% | +16.8% | -51.8% | |
| – | +347.8% | +5,347.4% | -94.3% | -1.7% | |
| – | – | -421.0% | – | -62.0% | |
| – | +198.0% | +118.8% | +15.7% | -13.5% | |
| – | +92.6% | +54.2% | +11.0% | -16.3% | |
| – | +152.5% | -52.0% | +389.5% | -17.9% | |
| – | – | – | – | – | |
| – | -67.5% | -100.0% | – | – | |
| – | – | – | – | – | |
| – | +739.5% | +212.5% | -168.7% | – | |
| – | – | – | – | – | |
| – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.